Spring Valley Acquisition IV Units (SVIVU) Stock Price, News & Analysis
What Changed
Price Move History
- Daily moves over 5%
- 0 80 sessions, February 10, 2026 to November 5, 2026
- Largest daily move
- -3.3% close of October 6, 2026
- 1-month change
- -2.8% closing prices, September 28, 2026 to November 5, 2026
Company Description
Spring Valley Acquisition IV Units (NASDAQ: SVIVU) is classified in the shell companies industry within the Financial Services sector.
SVIVU has declined 2.8% over the past month. The last closing price was $10.25.
This page collects what Stock Titan holds for SVIVU, including price data, SEC filings, and short interest trends.
Stock Performance
Spring Valley Acquisition IV Units (SVIVU) closed at $10.25 on November 5, 2026. Over the past month, the price has lost 2.8%.
SVIVU Metrics & Rankings
Price returns through November 5, 2026. Month and year figures include the first trading day. Ranking links may use different dates.
Latest News
SEC Filings
Spring Valley Acquisition IV Units has filed 7 recent SEC filings, including 3 Form SCHEDULE 13G, 2 Form 10-Q, 2 Form 8-K. The most recent filing was submitted on . SEC filings provide transparency into a company's financial condition, material events, and regulatory compliance. View all SVIVU SEC filings →
Short Interest History
Short interest in Spring Valley Acquisition IV Units (SVIVU) currently stands at 482 shares. Since February 2026, short interest has decreased by 98.9%.
Days to Cover History
Days to cover for Spring Valley Acquisition IV Units (SVIVU) currently stands at 1.7 days, up 63.5% from the previous period. The ratio is the reported short interest divided by the average daily trading volume. Since February 2026, the figure has increased by 70%. Across the settlements charted above, it has ranged from 1.0 to 1000.0 days.
SVIVU Company Profile & Sector Positioning
Spring Valley Acquisition IV Units (SVIVU) operates in the Shell Companies industry within the broader Financial Services sector and is listed on the NASDAQ.
Investors comparing SVIVU often look at related companies in the same sector, including Drugs Made In America Acquisition II Corp. (DMII), Churchill Capital Corp XI (CCXI), EQV Ventures Acquisition Corp. II (EVAC), Bain Capital GSS Investment Corp. (BCSS), and Cantor Equity Partners IV, Inc. (CEPF). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate SVIVU's relative position within its industry.